These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 17727468

  • 1. TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring.
    Cutroneo KR.
    Wound Repair Regen; 2007; 15 Suppl 1():S54-60. PubMed ID: 17727468
    [Abstract] [Full Text] [Related]

  • 2. How do glucocorticoids compare to oligo decoys as inhibitors of collagen synthesis and potential toxicity of these therapeutics?
    Cutroneo KR, Sterling KM.
    J Cell Biochem; 2004 May 01; 92(1):6-15. PubMed ID: 15095399
    [Abstract] [Full Text] [Related]

  • 3. How is Type I procollagen synthesis regulated at the gene level during tissue fibrosis.
    Cutroneo KR.
    J Cell Biochem; 2003 Sep 01; 90(1):1-5. PubMed ID: 12938150
    [Abstract] [Full Text] [Related]

  • 4. TGF-beta1-induced Smad 3 binding to the Smad 7 gene: knockout of Smad 7 gene transcription by sense phosphorothioate oligos, autoregulation, and effect on TGF-beta1 secretion: bleomycin acts through TGF-beta1.
    Cutroneo KR, Phan SH.
    J Cell Biochem; 2003 Jun 01; 89(3):474-83. PubMed ID: 12761881
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes.
    Meisler N, Shull S, Xie R, Long GL, Absher M, Connolly JP, Cutroneo KR.
    J Cell Biochem; 1995 Nov 01; 59(3):376-88. PubMed ID: 8567755
    [Abstract] [Full Text] [Related]

  • 6. Tissue fibrosis and carcinogenesis: divergent or successive pathways dictate multiple molecular therapeutic targets for oligo decoy therapies.
    Cutroneo KR, White SL, Chiu JF, Ehrlich HP.
    J Cell Biochem; 2006 Apr 15; 97(6):1161-74. PubMed ID: 16408276
    [Abstract] [Full Text] [Related]

  • 7. A novel nonsteroidal antifibrotic oligo decoy containing the TGF-beta element found in the COL1A1 gene which regulates murine schistosomiasis liver fibrosis.
    Boros DL, Singh KP, Gerard HC, Hudson AP, White SL, Cutroneo KR.
    J Cell Physiol; 2005 Aug 15; 204(2):370-4. PubMed ID: 15880383
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increase of collagen synthesis by obovatol through stimulation of the TGF-beta signaling and inhibition of matrix metalloproteinase in UVB-irradiated human fibroblast.
    Choi MS, Yoo MS, Son DJ, Jung HY, Lee SH, Jung JK, Lee BC, Yun YP, Pyo HB, Hong JT.
    J Dermatol Sci; 2007 May 15; 46(2):127-37. PubMed ID: 17346934
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad 3 binding to the proximal promoter of the Smad 7 gene.
    Cutroneo KR.
    J Cell Biochem; 2006 Apr 01; 97(5):933-9. PubMed ID: 16187293
    [Abstract] [Full Text] [Related]

  • 14. Differential gene expression in response to transforming growth factor-beta1 by fetal and postnatal dermal fibroblasts.
    Rolfe KJ, Irvine LM, Grobbelaar AO, Linge C.
    Wound Repair Regen; 2007 Apr 01; 15(6):897-906. PubMed ID: 18028139
    [Abstract] [Full Text] [Related]

  • 15. Promoter competitors as novel antifibrotics that inhibit transforming growth factor-beta induction of collagen and noncollagen protein synthesis in fibroblasts.
    Meisler NT, Chiu JF, Cutroneo KR.
    J Cell Biochem; 1999 Nov 01; 75(2):196-205. PubMed ID: 10502292
    [Abstract] [Full Text] [Related]

  • 16. Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1.
    Ghosh AK, Mori Y, Dowling E, Varga J.
    Biochem Biophys Res Commun; 2007 Mar 09; 354(2):420-6. PubMed ID: 17234156
    [Abstract] [Full Text] [Related]

  • 17. Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis.
    Martínez-Salgado C, Fuentes-Calvo I, García-Cenador B, Santos E, López-Novoa JM.
    Exp Cell Res; 2006 Jul 01; 312(11):2093-106. PubMed ID: 16624289
    [Abstract] [Full Text] [Related]

  • 18. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E, Buganim Y, Shapira KE, Besserglick H, Goldfinger N, Weisz L, Stambolsky P, Henis YI, Rotter V.
    Mol Cell Biol; 2007 Dec 01; 27(23):8228-42. PubMed ID: 17875924
    [Abstract] [Full Text] [Related]

  • 19. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W, Wang LW, Shi JZ, Gong ZJ.
    Hepatobiliary Pancreat Dis Int; 2009 Jun 01; 8(3):300-8. PubMed ID: 19502172
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneous response of nasal and lung fibroblasts to transforming growth factor-beta 1.
    Nonaka M, Pawankar R, Fukumoto A, Yagi T.
    Clin Exp Allergy; 2008 May 01; 38(5):812-21. PubMed ID: 18355371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.